Home Home Home Inbox Home Search

Event

Effectiveness of Acumapimod Oral P38 Inhibitor in the Treatment of Acute Severe Exacerbations of COPD: Results of the AETHER Phase II Trial

Location: 32A
Session Type: Late Breaking Mini Symposium
Monday
May
21
9:45 AM
10:00 AM

Speaker(s)/Author(s)

Jadwiga A. Wedzicha

MD, PhD
Imperial College London;National Heart and Lung Institute;National Heart and Lung Institute, Imperial College London

Jackie M. Parkin

MB,BS
Mereo BioPharma Group plc

Alastair MacKinnon

MB,BS
Mereo BioPharma Group plc

View Abstract

Effectiveness of Acumapimod Oral P38 Inhibitor in the Treatment of Acute Severe Exacerbations of COPD: Results of the AETHER Phase II Trial

Parent Sessions

  • B14 - LATE BREAKING CLINICAL TRIALS AND FIRST REPORTS IN ASTHMA AND COPD...
    05-21-2018 9:15 AM - 11:15 AM
    • Home Home Home Inbox Home Search